Pfizer Seeks Insights Into Big Data Analysis, Personalized Medicine Through Optum Labs

Pfizer VP Marc Berger says in an interview that his company joined the Optum Labs collaborative to look for insights on disease progression, help inform personalized medicine activities, and to work with others on developing and testing new methodologies for analyzing big data.